Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
07/16/2003 | CN1430596A New gamma selective retinoids |
07/16/2003 | CN1430521A Solid dispersion system of Pranlukast with improved dissolution, and the preparing method thereof |
07/16/2003 | CN1430518A Use of lactobacillus casei in immunostimulatory peptides |
07/16/2003 | CN1430508A Novel composition |
07/16/2003 | CN1429834A Fructus gleditsiae total saponin, its preparation method and use in preparation of medicine |
07/16/2003 | CN1429602A Medicine for treating throat disease and its preparation method |
07/16/2003 | CN1429601A Heat-Clearing away heat and toxic material and subsidence of swelling powder |
07/16/2003 | CN1429578A Medicinal atomization liquid for treating pharyngitis and its manufacturing process |
07/16/2003 | CN1429558A Mannosan peptide injection and its preparation and use method |
07/16/2003 | CN1429556A Muscle strong agent and anti-inflammatory agent |
07/16/2003 | CN1114604C Bicyclic aryl carboxamides and their therapeutic use |
07/16/2003 | CN1114597C Quinoline derivs |
07/16/2003 | CN1114426C Powder for treating throat disease and preparing process thereof |
07/15/2003 | US6593472 NK-1 receptor active amine oxide prodrugs |
07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
07/15/2003 | US6593354 Substituted benzoxazole compounds |
07/15/2003 | US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery |
07/15/2003 | US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
07/15/2003 | US6593335 Disease than can be ameliorated with a potassium channel opener in a host mammal, comprising administering to the mammal in need thereof a therapeutically effective amount of the compound of claim 1; said disease is epilepsy, Raynaud's |
07/15/2003 | US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof |
07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
07/15/2003 | US6592887 Mixture containing water soluble polymer |
07/15/2003 | US6592848 Ready to use aerosol packages |
07/10/2003 | WO2003056013A1 TGF-β-SPECIFIC COVALENTLY CLOSED ANTISENSE MOLECULE |
07/10/2003 | WO2003055983A2 Targeted retrograde gene delivery to motor neurons |
07/10/2003 | WO2003055913A2 Secreted protein |
07/10/2003 | WO2003055912A2 Secreted proteins |
07/10/2003 | WO2003055884A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
07/10/2003 | WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
07/10/2003 | WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
07/10/2003 | WO2003055875A1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
07/10/2003 | WO2003055874A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
07/10/2003 | WO2003055863A1 Novel alkansulfonamides as endothelin antagonists |
07/10/2003 | WO2003055558A1 Polyherbal composition for the treatment of bronchial asthma and the process |
07/10/2003 | WO2003055547A1 Medicament dispenser |
07/10/2003 | WO2003055481A1 Organ fibrosis inhibitors |
07/10/2003 | WO2003055474A1 Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine |
07/10/2003 | WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme |
07/10/2003 | WO2003055440A2 Compositions and methods for the treatement of immune related diseases |
07/10/2003 | WO2003055335A1 Modified methionine rich food products and process for their manufacture |
07/10/2003 | WO2003050119A3 Urea substituted imidazopyridines |
07/10/2003 | WO2003043905A3 Pharmaceutical product with an adsorbent |
07/10/2003 | WO2003035107A8 Enzyme inhibitors for inactivating allergens |
07/10/2003 | WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
07/10/2003 | WO2002092625A3 Moraxella(branhamella) catarrhalis antigens |
07/10/2003 | WO2002072788A3 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
07/10/2003 | WO2002059267A3 Constitutively desensitized g protein-coupled receptors |
07/10/2003 | WO2002013845A3 Inflammation related g-protein coupled receptor |
07/10/2003 | WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
07/10/2003 | WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
07/10/2003 | US20030131370 Disruption of the glutathione S-transferase-Omega-1 gene |
07/10/2003 | US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis. |
07/10/2003 | US20030130355 Serotonin/noradrenaline reuptake inhibitors (N-(1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl)-N,N-dimethylamine; dietetics; side effects reduction |
07/10/2003 | US20030130352 Such as 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E for treatment of cystic fibrosis |
07/10/2003 | US20030130333 Combination product and methods of use |
07/10/2003 | US20030130309 Antiinflammatory agents; rheumatic diseases |
07/10/2003 | US20030130292 Immunosuppressants; autoimmune disease; skin disorders; Crohn's disease; antidiabetic agents; anticancer agents; antiarthritic agents |
07/10/2003 | US20030130283 CRF receptor antagonists and methods relating thereto |
07/10/2003 | US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
07/10/2003 | US20030130277 Pyrazoloquinolinone derivatives as protein kinase C inhibitors |
07/10/2003 | US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
07/10/2003 | US20030130271 1,3-Diheterocyclic metalloprotease inhibitors |
07/10/2003 | US20030130266 Pharmacological treatment for sleep apnea |
07/10/2003 | US20030130263 Mixture of two antihistamines; sustained release |
07/10/2003 | US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents |
07/10/2003 | US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect |
07/10/2003 | US20030130218 Methods of stimulating phagocytosis |
07/10/2003 | US20030130203 Sleep disorders |
07/10/2003 | US20030130201 Mixture with ascorbic acid, proline and lysine |
07/10/2003 | US20030130200 Tripeptide or tetrapeptide |
07/10/2003 | US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/10/2003 | US20030130176 Spary drying dispersion; antiinflammatory agents; antihistamines; lung diseases |
07/10/2003 | US20030130168 Reverse-turn mimetics and methods relating thereto |
07/10/2003 | US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
07/10/2003 | US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier |
07/10/2003 | US20030129245 Mixing micronised formoterol its salt or solvate with a pre-micronised carrier/diluent at low energy, agglomerating and spheronisation or adding a coarse carrier/diluent; treating respiratory system disorders |
07/10/2003 | US20030129242 Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
07/10/2003 | US20030129237 Multiparticulate modified release composition |
07/10/2003 | US20030129205 Inducing presensitization of immune system towards an immunogen carrying lymphocytes epitope homologous to allergen; immunosuppressants |
07/10/2003 | US20030129141 Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery |
07/10/2003 | US20030129134 Method of monitoring neuroprotective treatment |
07/10/2003 | US20030129129 Prevention, therapy disease; forming tritiated water; calibration |
07/10/2003 | CA2471306A1 Secreted proteins |
07/10/2003 | CA2470666A1 Secreted protein |
07/10/2003 | CA2458751A1 Compositions and methods for the treatement of immune related diseases |
07/09/2003 | EP1325931A1 Inhibitors of human neutrophil elastase |
07/09/2003 | EP1325904A1 Novel aliphatic compounds, process for their preparation and their usage |
07/09/2003 | EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
07/09/2003 | EP1325765A1 Combinations of Formoterol and Mometasone Furoate for Asthma |
07/09/2003 | EP1325137A2 Truncated phosphodiesterase-7 polypeptides |
07/09/2003 | EP1325122A2 Modulation of the transcription of pro-inflammatory gene products |
07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
07/09/2003 | EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
07/09/2003 | EP1325009A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
07/09/2003 | EP1325008A1 Piperazine derivatives |
07/09/2003 | EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
07/09/2003 | EP1325001A1 Anticholinergic agents that can be used as medicaments and method for the production thereof |
07/09/2003 | EP1324994A2 Tricyclic compounds and uses thereof |